TX
10x Genomics
TXG·NASDAQPleasanton CAFounded 20121,400 employees
Mid CapbiotechPublicOncology
Platform: SingleCell
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (TXG)
Loading TXG stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mavucagene | TXG-2484 | Preclinical | 1 | C5 | Ewing SarcomaPsoriasis | ||
| TXG-6755 | TXG-6755 | Approved | 3 | CD123 | SMACML | ||
| Mirimavacamten | TXG-9552 | Phase 1 | 1 | PSMA | Myelofibrosis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)